BiVictriX Therapeutics (BVX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 15.90
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 82.53m
  • Volume: 14,569
  • Market Cap: £9.28m

Latest ShareCast News

BiVictriX gets patent for its lead asset in Japan

By Josh White

Date: Wednesday 15 Nov 2023

(Sharecast News) - BiVictriX Therapeutics has received a patent grant from the Japanese Patent Office (JPO) for its lead asset BVX001, it announced on Wednesday.

BiVictriX posts promising preclinical data on leukaemia candidate

By Josh White

Date: Thursday 12 Oct 2023

(Sharecast News) - Biotechnology company BiVictriX Therapeutics updated the market on the pre-clinical evaluation of BVX001 on Thursday - its first-in-class 'Bi-Cygni' antibody drug conjugate (ADC) developed for the potential treatment of acute myeloid leukaemia (AML).

BiVictriX appoints Adrian Howd as its new finance chief

By Josh White

Date: Tuesday 03 Oct 2023

(Sharecast News) - Biotechnology developer BiVictriX Therapeutics announced the appointment of Dr Adrian Howd as its chief financial officer (CFO) and chief business officer (CBO) on Tuesday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BVX Market Data

Currency UK Pounds
Share Price 11.25p
Change Today -0.50p
% Change -4.26 %
52 Week High 15.90
52 Week Low 10.50
Volume 14,569
Shares Issued 82.53m
Market Cap £9.28m

BVX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.93% below the market average50.93% below the market average50.93% below the market average50.93% below the market average50.93% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Price Trend
55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average55.09% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Income Not Available
Growth Not Available

BVX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:40 5 @ 10.50p
15:25 5 @ 10.50p
13:57 4,559 @ 11.55p

BVX Key Personnel

CEO Tiffany Jane Thorn

Top of Page